| ICD-10-CM-2023 > E00-E89 > E70-E88 > E79 |
E70-E88 | Metabolic disorders | |
Excl1.: | androgen insensitivity syndrome (E34.5-) congenital adrenal hyperplasia (E25.0) hemolytic anemias attributable to enzyme disorders (D55.-) Marfan's syndrome (Q87.4) 5-alpha-reductase deficiency (E29.1) | |
Excl2.: | Ehlers-Danlos syndromes (Q79.6-) | |
E79 | Disorders of purine and pyrimidine metabolism | |
Excl1.: | Ataxia-telangiectasia (Q87.19) Bloom's syndrome (Q82.8) Cockayne's syndrome (Q87.19) calculus of kidney (N20.0) combined immunodeficiency disorders (D81.-) Fanconi's anemia (D61.09) gout (M1A.-, M10.-) orotaciduric anemia (D53.0) progeria (E34.8) Werner's syndrome (E34.8) xeroderma pigmentosum (Q82.1) | |
E79.0 | Hyperuricemia without signs of inflammatory arthritis and tophaceous disease | |
Info: | Asymptomatic hyperuricemia | |
E79.1 | Lesch-Nyhan syndrome | |
Info: | HGPRT deficiency | |
E79.2 | Myoadenylate deaminase deficiency | |
E79.8 | Other disorders of purine and pyrimidine metabolism | |
Info: | Hereditary xanthinuria | |
E79.9 | Disorder of purine and pyrimidine metabolism, unspecified | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |